Regeneron Pharmaceuticals, Inc.
Methods and compositions comprising a combination of a VEGF antagonist and an anti-CTLA-4 antibody

Abstract:

The present invention provides pharmaceutical compositions comprising a VEGF antagonist and an anti-CTLA-4 antibody, and methods of use thereof. The compositions and methods of the present invention are useful for the treatment of cancers and other diseases and disorders in which anti-angiogenic therapies and/or targeted immune responses may be beneficial.